MedPath

西安风华药业有限公司

Ownership
-
Established
2004-08-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

138

NMPA:138

Drug Approvals

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H61020853
Approval Date
Nov 24, 2022
NMPA

Calcium Gluconate Buccal Tablets

Product Name
葡萄糖酸钙含片
Approval Number
国药准字H61021597
Approval Date
Nov 24, 2022
NMPA

Victamin C tablets

Product Name
维生素C片
Approval Number
国药准字H61021905
Approval Date
Nov 24, 2022
NMPA

Metoclopramide Tablets

Product Name
甲氧氯普胺片
Approval Number
国药准字H61020854
Approval Date
Nov 24, 2022
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H61021164
Approval Date
Nov 24, 2022
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H61022714
Approval Date
Nov 24, 2022
NMPA

Sulfamethoxazole,Salfadiazine and Trimethoprim Tablets

Product Name
联磺甲氧苄啶片
Approval Number
国药准字H61021160
Approval Date
Nov 24, 2022
NMPA

Calcium Gluconate Buccal Tablets

Product Name
葡萄糖酸钙含片
Approval Number
国药准字H61021596
Approval Date
Nov 24, 2022
NMPA

Compound Theopyl Lineand Ephedrine Tablets

Product Name
复方茶碱麻黄碱片
Approval Number
国药准字H61023314
Approval Date
Nov 24, 2022
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H61022387
Approval Date
Nov 24, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.